LASCCO Company

Lascco focuses on biomedical technologies developed by scientists devoted to their academic activities and remote from the entrepreneurial world. Recent years have witnessed the emergence of a number of public and private organizations providing seed capital, management support, and sometimes infrastructure, for the launching of start-up biotechcompanies. These financial and business supports are primarily directed at scientists willing or ready to embark on an entrepreneurial venture. Innovative technologies developed by scientists devoted to their academic activities and uninterested in an entrepreneurial venture remain unexploited and their value is kept buried. They aim at filling the gap between academic research and the pharmaceutical industry, by structuring and managing the progression of selected discovery-stage biomedical technologies from the academic lab all the way to the proof of concept in humans. Their constant goal is to broaden their connections with the pharmaceutical industry and to remain well informed of the unmet market needs on the one hand, and to consolidate their relationship with researchers and physicians on the other hand.
Technology: Others
Industry: Deep Diagnostics
Headquarters: Geneva
Founded Date: 01.01.2007
Estimated Revenue: $1B to $10B

Visit Website
http://twitter.com/LASCCO
Register and Claim Ownership